Cullinan Therapeutics, Inc. SEC filings CGEM
Cullinan Therapeutics, Inc. has 466 filings in SEC EDGAR's recent list, going back to Nov 2, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 2, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2026 | Sep 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 8, 2026 | Jun 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Agreement ended
|
Nov 21, 2025 | Nov 18, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 29, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2024 | Jun 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 15, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Apr 16, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K/A |
Amended current report
Results of operations
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Feb 14, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Jan 19, 2023 | Jan 17, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 2, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 25, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Jun 27, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 11, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2021 | Dec 27, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 18, 2021 | Oct 15, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 1, 2021 | Jun 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Officer or director change
|
May 21, 2021 | May 17, 2021 |
| 8-K |
Current report
Results of operations
|
May 14, 2021 | May 14, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2021 | Mar 30, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 26, 2021 | Feb 23, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 22, 2021 | Feb 22, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 13, 2021 | Jan 7, 2021 |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGEM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1789972
- Former names
- Cullinan Oncology, Inc. (until Apr 2, 2024); Cullinan Management, Inc. (until Feb 22, 2021); Cullinan Oncology, LLC (until Jan 6, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.